Company Coverage
Nexteer (1316 HK): 1H26: Net Profit Up 35.2% yoy As EMEASA Margins And A Lower Tax Rate More Than Offset Soft Volumes
BUY (Maintained)
Current price:
Target price:
Upside:
Previous TP :
HK$4.48
HK$11.40
154.5%
HK$8.30
Analyst
Highlights
- Nexteer's 1H26 net profit rose 35.2% yoy to US$85.8m, on a 3.9% yoy revenue growth and a 1.0ppt gain in adjusted EBITDA margin to 11.3%.
- Management has guided for the 2026 effective tax rate to be slightly below 25%, against the 33% assumed.
- We lift 2026-28 net profit forecasts by 20.6%/23.2%/22.0% respectively and roll the valuation base to 2027 at an unchanged 20x PE, taking our target price to HK$11.40 from HK$8.30.

Analysis
- Revenue rose 3.9% yoy to a record US$2,329m, with the Europe, Middle East and South America (EMEASA) segment up 11.6%, North America up
2.7%, and Asia Pacific up 3.2%. Excluding currency and commodity passthroughs, growth was 0.8%, or 180bp above a global production market that was down about 1%; however, this is short of the 200-300bp guided in March, which management attributed to weaker volumes in China.

- Adjusted EBITDA rose 14.1% yoy to US$263m, with margin expanding 1.0ppt to 11.3%. EMEASA drove the increase, contributing EBITDA of
US$55m (+56% yoy, +62% hoh) and a margin of 12.2% (+3.5ppt yoy, +3.7ppt hoh), underpinned by its regional margin enhancement programme.
Asia Pacific held at 16.9% despite pricing pressure and higher commodity costs, while North America slipped to 7.3% (−0.3ppt yoy) on a plant outage and adverse currency, with an insurance recovery expected in 2H26.
- US$8m of 2025 tariff costs were recovered, though nothing has yet been booked on the North American electric vehicle cancellations that cost
US$24m in 2H25. Depreciation and amortisation rose 6.1% yoy to US$146m, while the effective tax rate fell to 21.6% (-6.3ppt yoy), driven by stronger US profitability and tax planning. Minority interests accounted for 5.0% of profit (-3.0ppt yoy), and adjusted net profit increased 23.3% yoy to US$76m.
- Operating cash flow rose 84.2% yoy to US$262m and free cash flow reached US$109m (+197% yoy), lifting net cash to US$516m (+40.5% yoy) with total liquidity of US$968m. Capex and intangible additions rose 42.6% yoy to US$158m, so the improvement came from earnings and working capital, not underinvestment.
- Bookings reached US$3.3b (+120% yoy), tracking toward the reaffirmed fullyear target of US$6b, supported by 28 programme launches, 26 of which were for new or conquest business. First steer-by-wire production launches were achieved, though management does not expect the technology to contribute meaningfully to group revenue until after 2030. For 2H26, it flags price give-backs closer to 2% and no commodity escalation cover on Chinese
Highlights
- Nexteer's 1H26 net profit rose 35.2% yoy to US$85.8m, on a 3.9% yoy revenue growth and a 1.0ppt gain in adjusted EBITDA margin to 11.3%.
- Management has guided for the 2026 effective tax rate to be slightly below 25%, against the 33% assumed.
- We lift 2026-28 net profit forecasts by 20.6%/23.2%/22.0% respectively and roll the valuation base to 2027 at an unchanged 20x PE, taking our target price to HK$11.40 from HK$8.30.

Analysis
- Revenue rose 3.9% yoy to a record US$2,329m, with the Europe, Middle East and South America (EMEASA) segment up 11.6%, North America up
2.7%, and Asia Pacific up 3.2%. Excluding currency and commodity passthroughs, growth was 0.8%, or 180bp above a global production market that was down about 1%; however, this is short of the 200-300bp guided in March, which management attributed to weaker volumes in China.

- Adjusted EBITDA rose 14.1% yoy to US$263m, with margin expanding 1.0ppt to 11.3%. EMEASA drove the increase, contributing EBITDA of
US$55m (+56% yoy, +62% hoh) and a margin of 12.2% (+3.5ppt yoy, +3.7ppt hoh), underpinned by its regional margin enhancement programme.
Asia Pacific held at 16.9% despite pricing pressure and higher commodity costs, while North America slipped to 7.3% (−0.3ppt yoy) on a plant outage and adverse currency, with an insurance recovery expected in 2H26.
- US$8m of 2025 tariff costs were recovered, though nothing has yet been booked on the North American electric vehicle cancellations that cost
US$24m in 2H25. Depreciation and amortisation rose 6.1% yoy to US$146m, while the effective tax rate fell to 21.6% (-6.3ppt yoy), driven by stronger US profitability and tax planning. Minority interests accounted for 5.0% of profit (-3.0ppt yoy), and adjusted net profit increased 23.3% yoy to US$76m.
- Operating cash flow rose 84.2% yoy to US$262m and free cash flow reached US$109m (+197% yoy), lifting net cash to US$516m (+40.5% yoy) with total liquidity of US$968m. Capex and intangible additions rose 42.6% yoy to US$158m, so the improvement came from earnings and working capital, not underinvestment.
- Bookings reached US$3.3b (+120% yoy), tracking toward the reaffirmed fullyear target of US$6b, supported by 28 programme launches, 26 of which were for new or conquest business. First steer-by-wire production launches were achieved, though management does not expect the technology to contribute meaningfully to group revenue until after 2030. For 2H26, it flags price give-backs closer to 2% and no commodity escalation cover on Chinese
BUY (Maintained)
Current price:
Target price:
Upside:
Previous TP :
HK$4.48
HK$11.40
154.5%
HK$8.30
Analyst
IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at the following link: https://research-api.uobkayhian.com/assets/disclaimer/df64a6ea-7980-447c-ae9e-fd19b93257dc, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.
Related articles

17 Aug 2026
Huizhou Desay SV (002920 CH): 2Q26: Net Profit Up 22.3% yoy, Beating Our Estimate On Cost Control

27 Jul 2026
Contemporary Amperex Technology Co (300750 CH): 2Q26: In Line; Cutting Margins, Lifting Volumes

6 Aug 2026
BeOne Medicines (6160 HK): 1H26: Results Outperform, Further Lifting 2026 Outlook
Our latest research

17 Aug 2026
Huizhou Desay SV (002920 CH): 2Q26: Net Profit Up 22.3% yoy, Beating Our Estimate On Cost Control

17 Aug 2026
Kweichow Moutai (600519 CH): 2Q26: Results Missed; Stated-owned Investors Disposed Shares

14 Aug 2026
